相关实验视频

Updated: Jul 3, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

机器学习算法用于预测患有充血性心力衰竭与慢性病结合的危急病患者的住院死亡率

Xunliang Li^1,2, Zhijuan Wang^1,2, Wenman Zhao^1,2

¹Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.

|February 15, 2024

概括

这项研究开发了机器学习模型,以预测患有充血性心力衰竭和慢性病的重症患者的住院死亡率. 极端梯度提升模型显示了最高的准确性.

科学领域:

关键护理医学关键护理医学
生物医学信息学生物医学信息学
腎臟病學 (nephrology) 是一種醫學專業.

背景情况:

患有充血性心力衰竭 (CHF) 和慢性病 (CKD) 的重症患者面临高的住院死亡风险.
准确预测死亡率对于及时干预和资源分配至关重要.

研究的目的:

开发和验证机器学习 (ML) 模型,用于预测结合性慢性心血管疾病和慢性脏疾病的重症患者的住院死亡率.
确定这一患者群体中死亡率的关键预测因素.

主要方法:

利用了2008-2019年间5041名心血管衰竭和慢性病患者的数据 (MIMIC-IV数据库).
采用最小绝对收缩和选择操作员回归来进行特征选择,确定22个与死亡率相关的变量.
开发了6个ML模型,根据曲线下的面积 (AUC) 选择了最佳的模型.
使用夏普利添加式解释 (SHAP) 和局部可解释模型-不可知解释 (LIME) 的解释模型预测.

主要成果:

极端梯度增强 (XGBoost) 模型实现了0.837.7的最高AUC.
通过SHAP值确定的关键预测因素包括顺序器官衰竭评估 (SOFA) 评分,年龄,简化急性生理学评分II (SAPS II) 和尿液输出.
LIME提供了个性化的预测解释.

结论:

成功开发和验证了ML模型,用于预测CHF和CKD重病患者的住院死亡率.
与其他评估的ML模型相比,XGBoost模型显示出更高的疗效.
这些发现为这种复杂的患者群体的风险分层和临床决策提供了有价值的工具.

关键词:

充血性心力衰竭是因为慢性脏疾病慢性脏疾病关键的关怀关怀关键的关怀机器学习是机器学习.死亡率死亡率

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

相关概念视频

Heart Failure Drugs: Diuretics

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...